title: Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
authors.affiliation: Department of Hematology, Hôpital St Louis, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: A
authors.initials: A
authors.lastname: Devergie
authors.forename: F
authors.initials: F
authors.lastname: Lokiec
authors.forename: R
authors.initials: R
authors.lastname: Traineau
authors.forename: J M
authors.initials: JM
authors.lastname: Cosset
authors.forename: N
authors.initials: N
authors.lastname: Lemercier
authors.forename: F
authors.initials: F
authors.lastname: Varrin
authors.forename: M
authors.initials: M
authors.lastname: Cavazzana
authors.forename: H
authors.initials: H
authors.lastname: de Castro
authors.forename: J
authors.initials: J
authors.lastname: Meletis
mesh_terms: D001853:Bone Marrow / Q000276:immunology; D016026:Bone Marrow Transplantation; D002469:Cell Separation; D003524:Cyclosporins / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000166:cytology
chemical_list: D003524:Cyclosporins; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D008727:Methotrexate